# CRISPR Therapeutics (CRSP) — News

CRSP · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/crsp/news

## Recent headlines

- [First pricing secondary offering of stock at $22.20/shr](https://www.ainvest.com/news/pricing-secondary-offering-stock-22-20-shr-2608) — AInvest Wire, Aug 11, 2026
  A company has announced its first pricing secondary offering of stock at $22.20 per share, marking a significant step in its capital-raising strategy. Secondary offerings typically occur after an initial public offering (IPO) and can either be non-dilutive, where existing shareholders sell their…
- **Important** — [CRISPR Therapeutics rises 7.2%, Editas Medicine up 8.3% as FDA clears way for faster personalized gene editing treatments](https://www.ainvest.com/news/crispr-therapeutics-rises-7-2-editas-medicine-8-3-fda-clears-faster-personalized-gene-editing-treatments-2510) — AInvest Wire, Oct 31, 2025
- Crispr Therapeutics' stock soars 10% as FDA-panel meeting raises hopes sickle-cell-disease drug will be approved — AInvest Wire, Nov 1, 2023
- CRISPR Therapeutics climbs 18% premarket after reporting completion of FDA advisory committee meeting for Exagamglogene autotemcel (EXA-cel) for severe sickle cell disease — AInvest Wire, Nov 1, 2023

## Similar Stocks

- [VRTX](https://www.lighthorse.io/tickers/vrtx) — Vertex Pharmaceuticals Incorporated - Common Stock
- [MRNA](https://www.lighthorse.io/tickers/mrna) — Moderna, Inc. - Common Stock
- [NTLA](https://www.lighthorse.io/tickers/ntla) — Intellia Therapeutics, Inc. - Common Stock
- [KALA](https://www.lighthorse.io/tickers/kala) — KALA BIO, Inc. - Common Stock
- [BEAM](https://www.lighthorse.io/tickers/beam) — Beam Therapeutics Inc. - Common Stock
- [ALLO](https://www.lighthorse.io/tickers/allo) — Allogene Therapeutics, Inc. - Common Stock
- [AXSM](https://www.lighthorse.io/tickers/axsm) — Axsome Therapeutics, Inc. - Common Stock
- [EDIT](https://www.lighthorse.io/tickers/edit) — Editas Medicine, Inc. - Common Stock

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).